Giessen Pulmonary Hypertension Registry and Biobank
ConditionPulmonary Hypertension
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorUniversity of Giessen
About this trial
Giessen Pulmonary Hypertension Registry and Biobank
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Right heart catheterization for PH diagnosis in Giessen
Disqualifiers
informed consent missing
Trial population
Study population includes patients referred to our tertial PH expert center in Giessen with suspected PH.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
10,000 Participants
are grouped into 6 trial groups6
Trial groupsSee each trial group below.
Group A: Pulmonary arterial hypertension
Group B: Pulmonary hypertension due to left heart disease
Group C: Pulmonary hypertension due to lung disease
Group D: Chronic thromboembolic pulmonary hypertension
Group E: Miscellaneous
Group F: Exclusion PH
Trial outcomes
Primary outcomes
1
Survival
Transplant-free survival of PH patients
Time frame
Up to 20 years after enrollmentSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov